GraphiteRx and Mark Cuban Cost Plus Drugs Deepen Partnership to Advance Availability of Lower-Cost Medications
GraphiteRx and Mark Cuban Cost Plus Drugs today announced an expansion of their partnership to power the Cost Plus Marketplace for Businesses (CPM), reinforcing a shared commitment to improving the availability of more affordable medications for hospitals, pharmacies, and clinics. By pairing Cost Plus Drugs' innovative pricing model with GraphiteRx's industry-leading marketplace platform, the continued collaboration supports a more modern...
Read more









